Health

DALLAS (AP) — Federal health officials have confirmed that a patient being treated at a Dallas hospital has tested positive for Ebola. The case announced Tuesday by the Centers for Disease Control is the first Ebola case diagnosed in the United States. Officials at Texas Health...
WASHINGTON (AP) — From research grants to travel junkets, drug and medical device companies paid doctors and leading hospitals billions of dollars last year, the government disclosed Tuesday in a new effort to spotlight potential ethical conflicts in medicine. Industry spent...
WASHINGTON (AP) — From research grants to travel junkets, drug and medical device companies paid doctors and leading hospitals billions of dollars last year, the government disclosed Tuesday in a new effort to spotlight potential ethical conflicts in medicine. Industry spent...
PITTSBURGH (AP) — A psychiatric hospital has cited security concerns in its decision to refuse treatment to a teenager awaiting trial on charges he stabbed 20 fellow students and a security guard at his high school. Westmoreland County Judge Christopher Feliciani agreed with...
DENVER (AP) — The Colorado Supreme Court is considering a marijuana-related firing case that could have big implications for the state's pot smokers. The justices heard arguments Tuesday in the case of Brandon Coats, a quadriplegic medical marijuana patient who was fired from...
TRENTON, N.J. (AP) — The maker of the world's top-selling erectile dysfunction drug on Tuesday will begin airing the first Viagra TV commercial that targets the less-obvious sufferers of the sexual condition: women. In the new 60-second ad, a middle-aged woman reclining on a bed...
NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson is buying the biopharmaceutical company Alios BioPharma Inc. for about $1.75 billion. Alios is a privately held California-based company that focuses on developing therapies for viral diseases. The deal includes Alios' portfolio...
NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson is buying the biopharmaceutical company Alios BioPharma Inc. for about $1.75 billion. Alios is a privately held company that focuses on developing therapies for viral diseases. The deal includes Alios' portfolio of potential...
NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson is buying the biopharmaceutical company Alios BioPharma Inc. for about $1.75 billion. Alios is a privately held company that focuses on developing therapies for viral diseases. The deal includes Alios' portfolio of potential...